Veritone Inc (Veritone) is a provider of artificial intelligence computing solutions. The company is engaged in developing AI operating systems and applications that transform data into actionable insights. Veritone serves industries such as media, entertainment, advertising, and public sector organizations, including media broadcasters, advertisers, and film production companies.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Veritone focuses its R&D efforts on developing new features, maintaining AI technologies, and expanding core technologies to enhance the usability, functionality, reliability, performance, and flexibility of aiWARE. The company also aims to operate in new vertical markets and plans to continue making significant investments in developing AI technologies, expanding the functionality and capabilities of aiWARE and related solutions, and building new software capabilities. The R&D units of Veritone are organized in teams. These teams are responsible for the design, development, and testing of AI and software solutions. Specific roles within these teams include software engineers, quality engineers, data scientists, data engineers, product managers, and user experience designers. The teams focus on the core aiWARE architecture and capabilities, as well as solutions and applications that address specific use cases in key markets. As of December 31, 2025, Veritone had 39 patents issued in the US, which expire between 2029 and 2042, and ten patent applications pending for examination. Additionally, the company has 12 issued patents and four patent applications pending in foreign jurisdictions. In FY2025, the company incurred an expense of US$20.7 million on its R&D activities, which stood at 22% of the company’s total revenue.